MAXIM Assure Antibacterial Hand Soap Recalled for Microbial Contamination
Midlab Incorporated is recalling MAXIM Assure Antibacterial hand soap (Lot 0711241) nationwide due to out-of-specification microbial test results in the manufacturing process.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall due to cGMP deviations and out-of-specification microbial test results in manufacturing. Source does not report any illnesses or injuries, and the hazard is identified as a quality control issue requiring precautionary recall.
Plain-English summary
Midlab Incorporated is recalling MAXIM Assure Antibacterial, Chloroxylenol 0.1%, in one-gallon containers, Lot 0711241, due to cGMP deviations and out-of-specification results for microbial testing. The product was distributed nationwide in the USA for industrial and institutional use only.
The recall was initiated due to manufacturing quality control failures where microbial test results did not meet specified standards.
Institutional and commercial users who have purchased this product should discontinue use and contact Midlab Incorporated for additional information and instructions regarding replacement or refund.
The recalled product
- Product
- MAXIM Assure Antibacterial, Chloroxylenol 0.1%, Net Contents: One U.S. Gallon (3.78 L), For Industrial and Institutional Use Only, MIDLAB 140 Private Brand Way, Athens, TN 37303
- Manufacturer
- Midlab Incorporated
- Category
- Drug — Antimicrobial / Hand Soap
- Hazard
- cgmp-deviation
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 0711241
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27